Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Cullinan Oncology, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues0.018.90.016.89.6
            Revenue growth-100.0% -100.0%75.2% 
Cost of goods sold0.00.00.022.314.6
Gross profit0.018.90.0-5.5-5.0
            Gross margin 100.0% -32.7%-52.2%
Selling, general and administrative132.186.960.3  
General and administrative   5.55.0
EBIT-132.1-68.0-53.9-22.3-14.6
            EBIT margin -358.7% -132.7%-152.2%
Pre-tax income151.3-67.5-51.8-21.7-14.2
Income taxes42.10.00.00.00.0
            Tax rate27.8%0.0%0.0%0.0%0.0%
Net income111.2-65.6-51.8-21.7-14.2
            Net margin -346.1% -129.0%-148.0%
 
Diluted EPS$2.38($1.52)($2.60)($21,654.00)($14,189.00)
Shares outstanding (diluted)46.643.119.90.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy